TechSingapore’s billion-dollar IPs prepare to be marketed. What currently? by The Tamesis ” We have actually constructed a solid license base. However where is all of it going?” – Pauline Tay, National Facility for Health And Wellness Technology Post Views: 93 Share this Facebook X Telegram Whatsapp Email TagsbilliondollarcommercializedIPsReadySingaporesRelated Posts Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 20, 2026 Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 19, 2026 Tycoon Raj Kumar Selling Prime F&B Space In Singapore’s Orchard Road For $195 Million January 19, 2026 The TamesisLeave a Reply Cancel replyYour email address will not be published. Save my name, email, and website in this browser for the next time I comment. Previous StoryIndian home money start-up Nivara nets $28m collection B Next Story‘Disadvantage King’: Duterte, ICC, and the ‘Strong South’ Latest from Blog The Japanese Color Depositing Shampoo That Gradually Camouflages My Grays by The Tamesis Amy Sherald Signs With Talent Agency CAA by The Tamesis Bonhams Posts $970 Million in 2025 Sales as It Navigates a Market Reset by The Tamesis What Can Iran’s Cinema Tell Us About the Current Unrest? Quite a Lot, in Fact by The Tamesis How Interior Designer Madelynn Hudson Packs for Vacation by The Tamesis Mary Katrantzou Spring 2026 Ready-to-Wear Collection by The Tamesis You Can Find SZA Biking Around Paris—Or at the Louis Vuitton Men’s Show by The Tamesis 52 Walker Quietly Becomes a David Zwirner Gallery by The Tamesis Everything You Need to Know About Paul Poiret, the Turn-of-the-Century Couturier Referenced in the Fall 2026 Dior Men Collection by The Tamesis One Man’s Trash Is Another Man’s Treasure—Digging Into the Dirty Fashion Phenomenon by The TamesisRelated Posts Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 20, 2026 Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 19, 2026 Tycoon Raj Kumar Selling Prime F&B Space In Singapore’s Orchard Road For $195 Million January 19, 2026 Previous StoryIndian home money start-up Nivara nets $28m collection B Next Story‘Disadvantage King’: Duterte, ICC, and the ‘Strong South’
Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 20, 2026
Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 19, 2026
Tycoon Raj Kumar Selling Prime F&B Space In Singapore’s Orchard Road For $195 Million January 19, 2026
Everything You Need to Know About Paul Poiret, the Turn-of-the-Century Couturier Referenced in the Fall 2026 Dior Men Collection by The Tamesis
Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 20, 2026
Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes. January 19, 2026
Tycoon Raj Kumar Selling Prime F&B Space In Singapore’s Orchard Road For $195 Million January 19, 2026